Skip to main content
Livermore
Livermore
ZHEN

Nicholas Investment Partners, LP

SEC CIK
0001389574
Latest filing
Aug 14, 2026

The latest 13F from Nicholas Investment Partners, LP covers Q2 2026 (filed Aug 14, 2026): 204 long positions worth $1.78B. The top 10 holdings make up 17.9% of the portfolio, and the largest is BWX Technologies, Inc. (BWXT) at 3.0%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
44
Est. +$242.0M
Added
74
Est. +$186.5M
Reduced
41
Est. −$185.7M
Sold out
45
Est. −$184.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. BWXTBWX Technologies, Inc.
    3.0%$53.0MHistory
  2. RVMDRevolution Medicines, Inc.
    2.6%$45.8MHistory
  3. CALYCallaway Golf Co
    2.1%$36.7MHistory
  4. MODModine Manufacturing Co
    1.7%$29.7MHistory
  5. CRSCarpenter Technology Corp
    1.5%$26.9MHistory

Share of portfolio

Top 5 holdings and the other 199 positions, by share of portfolio value

  1. BWXT3.0%
  2. RVMD2.6%
  3. CALY2.1%
  4. MOD1.7%
  5. CRS1.5%
  6. Other 199 positions89.2%

Biggest buys

New and added positions, by estimated amount bought

  1. KTBKontoor Brands, Inc.
    +$21.8MNewHistory
  2. CALYCallaway Golf Co
    +$15.6MAddedHistory
  3. RYTMRhythm Pharmaceuticals, Inc.
    +$15.5MNewHistory
  4. LTHLife Time Group Holdings, Inc.
    +$14.2MNewHistory
  5. DNTHDianthus Therapeutics, Inc.
    +$13.2MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. KTBKontoor Brands, Inc.
    +1.23 pp0.0% → 1.2%History
  2. CALYCallaway Golf Co
    +0.94 pp1.1% → 2.1%History
  3. RYTMRhythm Pharmaceuticals, Inc.
    +0.87 pp0.0% → 0.9%History
  4. LTHLife Time Group Holdings, Inc.
    +0.80 pp0.0% → 0.8%History
  5. DNTHDianthus Therapeutics, Inc.
    +0.71 pp0.3% → 1.0%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. BEBloom Energy Corp
    −$33.6MReducedHistory
  2. KTOSKratos Defense & Security Solutions, Inc.
    −$27.6MSold outHistory
  3. EMBJEmbraer S.A.
    −$25.4MSold outHistory
  4. NUVLNuvalent, Inc.
    −$18.8MReducedHistory
  5. CRDOCredo Technology Group Holding Ltd
    −$17.9MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. INSMINSMED Inc
    −2.00 pp2.2% → 0.2%History
  2. KTOSKratos Defense & Security Solutions, Inc.
    −1.99 pp2.0% → 0.0%History
  3. EMBJEmbraer S.A.
    −1.83 pp1.8% → 0.0%History
  4. NUVLNuvalent, Inc.
    −1.13 pp1.2% → 0.1%History
  5. BEBloom Energy Corp
    −1.08 pp1.1% → <0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.78B
+$390.0M (+28.1%) vs. prior quarter
Positions
204
−1 vs. prior quarter
Top 10 concentration
17.9%
Top 10 as share of value
Turnover
23.4%
Q2 2026, one quarter
Average holding period
7.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.78B (Q2 2026)

Q1 2021: $1.43BQ2 2021: $1.59BQ3 2021: $1.37BQ4 2021: $1.58BQ1 2022: $1.41BQ2 2022: $1.06BQ3 2022: $1.08BQ4 2022: $1.14BQ1 2023: $1.32BQ2 2023: $1.46BQ3 2023: $1.34BQ4 2023: $854.6MQ1 2024: $976.3MQ2 2024: $963.9MQ3 2024: $1.09BQ4 2024: $1.14BQ1 2025: $971.1MQ2 2025: $1.12BQ3 2025: $1.31BQ4 2025: $1.37BQ1 2026: $1.39BQ2 2026: $1.78B
Q1 2021Q2 2026
13F filings of Nicholas Investment Partners, LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026204$1.78BBWXTRVMDCALYvs. Q1 2026SEC
Q1 2026May 15, 2026205$1.39BBWXTINSMKTOSvs. Q4 2025SEC
Q4 2025Feb 13, 2026205$1.37BBWXTINSMKTOSvs. Q3 2025SEC
Q3 2025Nov 14, 2025211$1.31BBWXTKTOSRSIvs. Q2 2025SEC
Q2 2025Aug 14, 2025211$1.12BBWXTEMBJRSIvs. Q1 2025SEC
Q1 2025May 15, 2025192$971.1MEMBJBWXTREVGvs. Q4 2024SEC
Q4 2024Feb 14, 2025220$1.14BBWXTEMBJEVRvs. Q3 2024SEC
Q3 2024Nov 12, 2024218$1.09BBWXTFTAIEMBJvs. Q2 2024SEC
Q2 2024Aug 8, 2024195$963.9MMPWRBWXTWFRDvs. Q1 2024SEC
Q1 2024May 14, 2024201$976.3MBWXTMPWRXOMvs. Q4 2023SEC
Q4 2023Feb 8, 2024192$854.6MMPWRBWXTCELHvs. Q3 2023SEC
Q3 2023Nov 13, 2023184$1.34BARGXKRYSLEGNvs. Q2 2023SEC
Q2 2023Aug 10, 2023190$1.46BKRYSLEGNAPLSvs. Q1 2023SEC
Q1 2023May 12, 2023187$1.32BARGXLNTHESTAvs. Q4 2022SEC
Q4 2022Feb 10, 2023177$1.14BRXDXCYTKARGXvs. Q3 2022SEC
Q3 2022Nov 14, 2022175$1.08BRXDXSWAVEXEvs. Q2 2022SEC
Q2 2022Aug 10, 2022173$1.06BARGXITCIEXEvs. Q1 2022SEC
Q1 2022May 10, 2022191$1.41BITCIEXEARGXvs. Q4 2021SEC
Q4 2021Feb 14, 2022194$1.58BITCILSCCMPWRvs. Q3 2021SEC
Q3 2021Nov 15, 2021188$1.37BKRNTBHVNDNAvs. Q2 2021SEC
Q2 2021Aug 10, 2021199$1.59BBHVNBBIORGENvs. Q1 2021SEC
Q1 2021May 14, 2021184$1.43BTGTXBBIORGEN–SEC